<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Sexton Adcock | Activity</title>
	<link>https://www.catswannabecats.com/members/porterpark40/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/porterpark40/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Sexton Adcock.</description>
	<lastBuildDate>Mon, 29 Jun 2026 10:35:48 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">23b491b018f958fc10364533ee9ddd3f</guid>
				<title>Sexton Adcock posted an update: In this review, we highlight the design and construction of [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/23692/</link>
				<pubDate>Sun, 08 Jun 2025 10:18:27 -0400</pubDate>

									<content:encoded><![CDATA[<p>In this review, we highlight the design and construction of conceptually interesting and clinically viable actively targeted cancer nanomedicines containing small molecular drugs, nucleic acid drugs, or protein/peptide drugs, discuss their pros and cons, and give perspectives on the future developments and clinical translation. We are convinced&hellip;<span class="activity-read-more" id="activity-read-more-23692"><a href="https://www.catswannabecats.com/activity/p/23692/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">d301fc2922c8bc7db3b4d45e1c330301</guid>
				<title>Sexton Adcock posted an update: 80-0.97 recall and a 0.69-0.84 precision at a rate of 8.6 [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/5548/</link>
				<pubDate>Sat, 31 May 2025 15:00:46 -0400</pubDate>

									<content:encoded><![CDATA[<p>80-0.97 recall and a 0.69-0.84 precision at a rate of 8.6 ms/word.</p>
<p>96% of biodiversity literature titles. For three different data sets, they resulted in a 0.80-0.97 recall and a 0.69-0.84 precision at a rate of 8.6 ms/word.</p>
<p> Statistical methods used by most morphologists to validate species boundaries (such as principal component analysis&hellip;<span class="activity-read-more" id="activity-read-more-5548"><a href="https://www.catswannabecats.com/activity/p/5548/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">419be28e42edaefbee3becc92fd03989</guid>
				<title>Sexton Adcock became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/5182/</link>
				<pubDate>Sat, 31 May 2025 14:33:29 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>